Imaging confirms it! Chronic NF-kB activation creates crosstalk between the pathways. We also knew this chronic NF-kB was causing the drug resistance, because when we inhibit it (with ibrutinib) we can re-sensitize the cells. But the link between cRel and MCL1 is new. Is it real?
0 likes 1 replies
?